| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Dec 18, 2025 | Verastem, Inc. | Director | Sell | 37.5 | -592 | -0.58% | ✗ | $5.4K |
| Sep 16, 2025 | Sep 18, 2025 | Verastem, Inc. | Director | Sell | 37.5 | -587 | -0.57% | ✗ | $5.9K |
| Jun 16, 2025 | Jun 20, 2025 | Verastem, Inc. | Director | Sell | 37.5 | -594 | -0.58% | ✗ | $3.4K |
| Jun 13, 2025 | Jun 17, 2025 | PUMA BIOTECHNOLOGY, INC. | Director | Sell | 32.5 | -8,100 | -7.86% | ✓ | $27.5K |
| Mar 17, 2025 | Mar 19, 2025 | Verastem, Inc. | Director | Sell | 37.5 | -593 | -0.62% | ✗ | $4.1K |
| Dec 16, 2024 | Dec 20, 2024 | Verastem, Inc. | Director | Sell | 37.5 | -929 | -0.97% | ✗ | $4.2K |
| Sep 19, 2024 | Sep 20, 2024 | Verastem, Inc. | Director | Sell | 45.0 | -336 | -0.35% | ✗ | $937.4 |
| Sep 16, 2024 | Sep 18, 2024 | Verastem, Inc. | Director | Sell | 37.5 | -600 | -0.62% | ✗ | $1.7K |
| Jun 17, 2024 | Jun 20, 2024 | Verastem, Inc. | Director | Sell | 85.0 | +7,405 | 8.26% | ✗ | $3.1K |
| Jun 13, 2024 | Jun 17, 2024 | PUMA BIOTECHNOLOGY, INC. | Director | Sell | 23.8 | -9,900 | -16.79% | ✓ | $33.5K |
| Mar 18, 2024 | Mar 20, 2024 | Verastem, Inc. | Director | Sell | 37.5 | -810 | -0.90% | ✗ | $8.6K |
| Dec 18, 2023 | Dec 20, 2023 | Verastem, Inc. | Director | Sell | 37.5 | -761 | -0.83% | ✗ | $5.8K |
| Sep 18, 2023 | Sep 20, 2023 | Verastem, Inc. | Director | Sell | 37.5 | -752 | -0.82% | ✗ | $7.4K |
| Jun 16, 2023 | Jun 21, 2023 | Verastem, Inc. | CEO | Sell | 37.5 | -762 | -0.82% | ✗ | $7.7K |
| Jun 13, 2023 | Jun 15, 2023 | PUMA BIOTECHNOLOGY, INC. | Director | Sell | 91.3 | +17,100 | 40.85% | ✓ | $34.3K |
| Mar 16, 2023 | Mar 20, 2023 | Verastem, Inc. | CEO | Sell | 37.5 | -9,784 | -0.87% | ✗ | $4K |
| Dec 16, 2022 | Dec 20, 2022 | Verastem, Inc. | CEO | Sell | 26.3 | -28,718 | -2.49% | ✗ | $11.4K |
| Sep 19, 2022 | Sep 21, 2022 | Verastem, Inc. | CEO | Sell | 45.0 | -3,355 | -0.29% | ✗ | $3.8K |
| Aug 1, 2022 | Aug 2, 2022 | Verastem, Inc. | CEO | Sell | 37.5 | -5,858 | -0.50% | ✗ | $6.3K |
| Jun 21, 2022 | Jun 22, 2022 | Verastem, Inc. | CEO | Sell | 45.0 | -3,362 | -0.29% | ✗ | $3.8K |
| Jun 16, 2022 | Jun 21, 2022 | PUMA BIOTECHNOLOGY, INC. | Director | Sell | 18.8 | -13,000 | -23.70% | ✓ | $34.9K |
| May 14, 2022 | May 17, 2022 | Verastem, Inc. | CEO | Sell | 83.8 | +36,206 | 3.21% | ✗ | $14.2K |
| May 2, 2022 | May 4, 2022 | Verastem, Inc. | CEO | Sell | 37.5 | -5,857 | -0.52% | ✗ | $8.3K |
| Mar 21, 2022 | Mar 23, 2022 | Verastem, Inc. | CEO | Sell | 45.0 | -3,507 | -0.31% | ✗ | $4.5K |
| Jan 31, 2022 | Feb 2, 2022 | Verastem, Inc. | CEO | Sell | 45.0 | -5,695 | -0.50% | ✗ | $8.4K |
| Jan 3, 2022 | Jan 5, 2022 | Verastem, Inc. | CEO | Sell | 22.5 | -26,033 | -2.23% | ✗ | $53.4K |
| Dec 20, 2021 | Dec 22, 2021 | Verastem, Inc. | CEO | Sell | 26.3 | -13,682 | -1.16% | ✗ | $31.1K |
| Nov 1, 2021 | Dec 17, 2021 | Verastem, Inc. | CEO | Sell | 91.3 | +357,161 | 43.28% | ✗ | $15.1K |
| Sep 28, 2018 | Oct 2, 2018 | Verastem, Inc. | Director | Buy | 90.0 | +1,000 | 100.00% | ✗ | $7.3K |